Life Sciences Industry News – Page 4

SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

Posted on April 20, 2021 by Denise Bell

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. The data presented at the meeting include preclinical and Phase 1 clinical data evaluating the potential anti-cancer activity of the PKM2 activator […]

Innovative Med Tech Startup Xenter Announces Company Launch

Posted on April 20, 2021 by Denise Bell

Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is innovating new wireless technologies and techniques for the treatment of heart and vascular disease. The company’s next-generation devices will integrate functions that formerly required multiple costly devices. “We are bringing the world’s […]

IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

Posted on April 20, 2021 by Denise Bell

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]

IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards

Posted on April 14, 2021 by Denise Bell

Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the ‘Diagnostic and Beyond’ category. Although IONIQ did not win the category, being among the top finalists is a signiicant distinction. Placement was determined by companies receiving the most votes. “We’re on a mission to modernize cancer detection […]

Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®

Posted on April 14, 2021 by Denise Bell

Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses Co-Diagnostics CoPrimer™ technology, is now available through Walgreens Find Care®, allowing consumers a convenient, non-invasive option for PCR-based COVID-19 testing from their own. Dwight Egan, Co-Diagnostics CEO, stated, “Co-Diagnostics is proud that our technology will be available […]

The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

Posted on April 14, 2021 by Denise Bell

Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]

Novel Embolic Device Used for Arterial and Venous Tumor Treatments

Posted on February 5, 2021 by Denise Bell

Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term […]

SDP Oncology Announces First Patient Dosed in Phase 1/2 Study of TP-0184 for the Treatment of Anemia in Patients with Low or Intermediate Risk Myelodysplastic Syndromes

Posted on January 25, 2021 by Denise Bell

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed in a Phase 1/2 study evaluating the investigational agent TP-0184, an activin receptor-like kinase 2 (ALK2) and ALK5 inhibitor, for the treatment of anemia in adult patients with low or intermediate risk myelodysplastic syndromes (MDS). “The management of […]

Gentex Announces New Nanofiber Sensing Technology

Posted on January 14, 2021 by admin

Press Release Courtesy of Gentex ZEELAND, Mich., Jan. 12, 2021 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX) today announced the acquisition of a new nanofiber sensing technology capable of detecting a wide variety of chemicals, from explosives to volatile organic compounds, with widespread application in a multitude of industries. Gentex is a long-time supplier of electro-optical products for the global […]

Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products

Posted on January 13, 2021 by Denise Bell

Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly revenue for the company is anticipated to be the highest in the company’s history and to surpass analyst estimates. Analysts’ estimates for the fourth quarter ranged from $24 million to $25.98 million. Quarterly revenue is anticipated to […]

Clene Nanomedicine Closes Merger with Tottenham Acquisition I Limited; Provides Corporate Update

Posted on January 13, 2021 by Denise Bell

Clene Nanomedicine, Inc. (Clene) last week announced the closing of a merger with Tottenham Acquisition I Limited (“Tottenham”) and provided a corporate update. Proceeds from this transaction totaled approximately $31.9 million. The combined, publicly traded company is operating under the name Clene Inc., and its common stock began trading on the NASDAQ Capital Market on […]

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

Posted on January 13, 2021 by Denise Bell

Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression and improving health outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). This first of its kind program is expected to improve patient outcomes and provide meaningful cost reductions for healthcare providers and […]